AEON Biopharma, Inc. Quarterly Return On Assets in % from Q3 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
AEON Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2023.
  • AEON Biopharma, Inc. Return On Assets for the quarter ending September 30, 2023 was -2.17K %, a 108229% decline year-over-year.
  • AEON Biopharma, Inc. annual Return On Assets for 2022 was -25 %, a 945% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -2.17K -2.17K -108229% Jul 22, 2023 Sep 30, 2023
Q2 2023 -27.2 -31 -814% Jul 1, 2023 Jul 21, 2023
Q1 2023 -49.8 -51.5 -3064% Jan 1, 2023 Mar 31, 2023
Q4 2022 -25 -27.9 -945% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2 -5.82 -152% Jul 1, 2022 Sep 30, 2022
Q2 2022 3.81 Apr 1, 2022 Jun 30, 2022
Q1 2022 1.68 Jan 1, 2022 Mar 31, 2022
Q4 2021 2.96 Oct 1, 2021 Dec 31, 2021
Q3 2021 3.82 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.